Aortic Aneurysm

Table of Contents

  1. Overview
  2. Epidemiology
  3. Pathophysiology
  4. Etiology and Risk Factors
  5. Clinical Presentation
  6. Diagnosis
  7. Classification (Crawford and Other Systems)
  8. Treatment and Surgical Indications
  9. EVAR vs. Open Repair
  10. Surveillance Guidelines
  11. Complications
  12. Prognosis
  13. Prevention
  14. Recent Research
  15. References

1. Overview

An aortic aneurysm is a pathological, permanent, and localized dilation of the aorta exceeding 1.5 times its normal diameter, or a diameter greater than 3.0 cm in the abdominal aorta and greater than 4.0–5.0 cm in the thoracic aorta. Aneurysms may occur anywhere along the aorta but are most commonly classified anatomically as abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA), with a subset termed thoracoabdominal aortic aneurysms (TAAA) when they span both anatomic regions.

The condition carries significant morbidity and mortality, primarily due to the risk of rupture, dissection, or thromboembolic complications. Because most aneurysms are asymptomatic until a catastrophic event occurs, screening, surveillance, and timely surgical or endovascular intervention are cornerstone strategies in management. This article provides a comprehensive clinical review suitable for cardiovascular surgeons, vascular specialists, cardiologists, and internists involved in the care of patients with known or suspected aortic disease.

Back to Table of Contents

2. Epidemiology

Aortic aneurysms represent a significant public health burden worldwide. The estimated prevalence of AAA in men over 65 years of age ranges from 4% to 8% in Western populations, with a markedly lower prevalence of 0.5–1.5% in women of the same age group. The incidence of TAA is approximately 10.4 per 100,000 person-years, with ascending aortic aneurysms accounting for roughly 60% of thoracic cases.

Key epidemiological features include:

The prevalence of AAA has declined in several high-income countries over the past two decades, attributed in part to reductions in smoking rates and improvements in cardiovascular risk factor management. Despite this trend, the aging global population sustains a high absolute burden of disease.

Back to Table of Contents

3. Pathophysiology

The pathogenesis of aortic aneurysm is multifactorial, involving inflammatory, proteolytic, hemodynamic, and genetic mechanisms that collectively degrade the structural integrity of the aortic wall.

Extracellular Matrix Degradation

Central to aneurysm formation is the breakdown of elastin and collagen within the tunica media and adventitia. Matrix metalloproteinases (MMPs), particularly MMP-2, MMP-9, MMP-12, and ADAM family members, are upregulated within the aneurysm wall and are elaborated by infiltrating macrophages, neutrophils, and smooth muscle cells. This proteolytic cascade leads to progressive loss of medial lamellar structure and biomechanical failure.

Inflammatory Infiltration

Histopathological analysis of AAA tissue reveals a dense transmural inflammatory infiltrate composed predominantly of macrophages, T lymphocytes, and B lymphocytes. This chronic inflammation drives ongoing proteolysis, neovascularization, and smooth muscle cell apoptosis. Oxidative stress and reactive oxygen species further amplify tissue injury. In contrast, non-inflammatory aneurysms may be seen in connective tissue disorders where the primary defect is intrinsic to the structural proteins themselves.

Hemodynamic Factors

Aortic wall stress is governed by the Law of Laplace: wall tension = (pressure × radius) / (2 × wall thickness). As the aneurysm enlarges, wall tension increases disproportionately, predisposing to accelerated expansion and eventual rupture. Infrarenal aortic flow characteristics — including increased pulsatility, oscillating shear stress, and intraluminal thrombus formation — contribute to localized ischemia and biological activity that accelerate degeneration.

Genetic and Connective Tissue Disorders

Heritable conditions affecting the aorta include:

Intraluminal Thrombus

Most large AAAs harbor an intraluminal thrombus (ILT), which, paradoxically, does not appear to protect the wall from elevated stress. The ILT is metabolically active, harboring proteases and hypoxia-inducing conditions that further degrade the underlying aortic wall.

Back to Table of Contents

4. Etiology and Risk Factors

The etiology of aortic aneurysm spans degenerative, inflammatory, infectious, traumatic, and genetic categories.

Degenerative (Most Common)

The vast majority of AAAs and many TAAs result from atherosclerosis-related medial degeneration, though contemporary understanding recognizes that the process is distinct from typical luminal atherosclerosis. Shared risk factors include:

Inflammatory Aneurysms

Accounting for approximately 5–10% of AAAs, inflammatory aortic aneurysms are characterized by perianeurysmal fibrosis, dense adventitial inflammation, and frequent adherence to surrounding structures (duodenum, left renal vein, inferior vena cava). They may present with constitutional symptoms, elevated ESR/CRP, and a distinctive CT appearance with periaortic soft tissue rind.

Infectious (Mycotic) Aneurysms

Mycotic aneurysms result from bacterial seeding of the aortic wall, most commonly by Salmonella species, Staphylococcus aureus, and Streptococcus species. They are typically saccular, rapidly expanding, and carry high rupture risk. Risk factors include bacteremia, endocarditis, immunosuppression, and IV drug use.

Post-Dissection Aneurysm

Chronic aortic dissection (particularly type B) may result in progressive aneurysmal dilation of the false lumen. These post-dissection aneurysms have distinct wall properties and require careful surveillance.

Connective Tissue and Genetic Causes

As outlined in the pathophysiology section, Marfan syndrome, Loeys-Dietz syndrome, BAV aortopathy, and familial TAA syndromes represent important genetic etiologies, often presenting at younger ages and requiring individualized surgical thresholds.

Traumatic Aneurysm

Blunt thoracic trauma, most commonly from deceleration injuries, can cause acute aortic injury at the aortic isthmus (just distal to the left subclavian artery). If not immediately fatal, these may evolve into pseudoaneurysms. Endovascular repair is now preferred for most cases.

Back to Table of Contents

5. Clinical Presentation

The clinical presentation of aortic aneurysm spans a wide spectrum from entirely asymptomatic (the most common scenario) to life-threatening emergency.

Asymptomatic Aneurysm

The majority of aortic aneurysms are discovered incidentally on imaging performed for unrelated indications (e.g., abdominal ultrasound, CT scan for nephrolithiasis or pulmonary disease). Routine screening programs also identify a significant proportion of cases.

Symptomatic (Unruptured) Aneurysm

Symptomatic but intact aneurysms may present with:

Ruptured Aortic Aneurysm

Rupture constitutes a surgical emergency with extremely high mortality. The classic triad consists of:

  1. Sudden-onset severe abdominal, back, or flank pain — often described as tearing or ripping
  2. Hypotension or hemodynamic instability
  3. Pulsatile abdominal mass

However, this complete triad is present in only 25–50% of cases. Retroperitoneal ruptures may be temporarily tamponaded, allowing transient hemodynamic stability. Frank intraperitoneal rupture leads to rapid hemodynamic collapse and death without immediate intervention. Rupture into adjacent structures (aortocaval fistula, aortoenteric fistula) may produce distinctive presentations including continuous abdominal bruit, high-output cardiac failure, or GI hemorrhage.

Thoracic Aortic Aneurysm Presentations

Chest pain, back pain, or dyspnea may occur. Ascending aneurysms may cause aortic regurgitation due to annular dilation. Arch aneurysms may involve the great vessels. Descending thoracic aneurysms may erode into the esophagus (aortoesophageal fistula) presenting with massive hematemesis, or into the bronchial tree (aortobronchial fistula) with hemoptysis.

Back to Table of Contents

6. Diagnosis

Accurate diagnosis requires identification of the aneurysm, precise anatomic characterization, and assessment of associated pathology. Imaging is the cornerstone of diagnosis.

Ultrasound

Abdominal duplex ultrasonography is the primary screening modality for AAA. It is noninvasive, inexpensive, radiation-free, and has sensitivity exceeding 95% and specificity approaching 100% for infrarenal AAA. Limitations include poor visualization of suprarenal or iliac extension and inability to adequately image TAA. Ultrasound is appropriate for initial diagnosis and serial surveillance of stable infrarenal AAA.

Computed Tomography Angiography (CTA)

CTA with contrast is the definitive preoperative planning modality. It provides precise measurements of aneurysm diameter, length, and morphology; delineates the relationship to renal arteries, visceral vessels, and iliac bifurcation; identifies associated pathology (thrombus, calcification, occlusive disease); and is essential for EVAR planning. For thoracic and thoracoabdominal aneurysms, CTA with electrocardiographic gating is preferred to minimize cardiac motion artifact for the ascending aorta.

Key measurements reported in CTA include:

Magnetic Resonance Angiography (MRA)

MRA with gadolinium provides excellent soft-tissue characterization and avoids ionizing radiation. It is particularly useful for patients with contrast allergy (gadolinium-based agents may be used when iodinated contrast is contraindicated) and for assessing connective tissue disorders. Limitations include longer acquisition time, contraindication in patients with certain metallic implants, and potential for gadolinium-associated nephrogenic systemic fibrosis in advanced renal failure.

Aortography

Conventional catheter-based aortography has been largely supplanted by CTA/MRA for diagnostic purposes but remains used adjunctively during endovascular interventions to assess branch vessel involvement, confirm device positioning, and identify endoleaks after EVAR.

Echocardiography

Transthoracic echocardiography (TTE) provides assessment of the aortic root and proximal ascending aorta and is useful for evaluating associated bicuspid aortic valve, aortic regurgitation, and left ventricular function. Transesophageal echocardiography (TEE) offers superior visualization of the descending thoracic aorta and is useful intraoperatively.

Laboratory Evaluation

No serum biomarker has sufficient sensitivity or specificity for clinical diagnosis. Elevated serum MMP-9 and D-dimer may correlate with aneurysm activity and rupture risk in research settings. Standard preoperative labs include CBC, comprehensive metabolic panel, coagulation studies, type and screen, and creatinine/eGFR for contrast-related planning.

Back to Table of Contents

7. Classification (Crawford and Other Systems)

Several classification systems are used to characterize aortic aneurysms anatomically, guiding surgical planning, risk stratification, and prognostication.

Crawford Classification of Thoracoabdominal Aortic Aneurysms

Proposed by E. Stanley Crawford, this classification divides TAAAs based on extent of aortic involvement and relationship to visceral and renal vessels, directly informing operative approach and predicting spinal cord ischemia risk:

Stanford and DeBakey Classifications (Aortic Dissection)

While primarily used for dissection, these classifications are relevant to post-dissection aneurysm:

Anatomic Location Classification

Morphology

Back to Table of Contents

8. Treatment and Surgical Indications

Management encompasses medical therapy for all patients, surveillance for those below repair thresholds, and intervention (endovascular or open surgical) when risk of rupture or complications outweighs procedural risk.

Medical Management

All patients with aortic aneurysm should receive aggressive medical management targeting modifiable risk factors:

Indications for Repair: Abdominal Aortic Aneurysm

Current guidelines from the Society for Vascular Surgery (SVS), American College of Cardiology/American Heart Association (ACC/AHA), and European Society for Vascular Surgery (ESVS) recommend repair based on diameter thresholds and other criteria:

Indications for Repair: Thoracic Aortic Aneurysm

Indications for Repair: Thoracoabdominal Aortic Aneurysm

Back to Table of Contents

9. EVAR vs. Open Repair

The choice between endovascular aortic repair (EVAR) and open surgical repair is determined by anatomical suitability, patient physiologic status, institutional expertise, and long-term durability considerations.

Endovascular Aortic Repair (EVAR / TEVAR)

EVAR for infrarenal AAA involves percutaneous or femoral cutdown delivery of a modular stent-graft system that excludes the aneurysm sac from arterial pressure. TEVAR (thoracic EVAR) applies the same principle to descending thoracic aneurysms.

Anatomic requirements for standard EVAR:

Advantages of EVAR:

Disadvantages and limitations of EVAR:

Advanced Endovascular Techniques

Open Surgical Repair

Open AAA repair involves aortic clamping, aneurysm sac opening, mural thrombus removal, and placement of a prosthetic Dacron graft (tube or bifurcated). The transperitoneal midline approach or retroperitoneal approach (preferred for suprarenal, hostile abdomen, or horseshoe kidney) is used.

Advantages of open repair:

Disadvantages of open repair:

Open Repair of TAAA

Open TAAA repair (Crawford-type) is among the most physiologically demanding vascular operations. Spinal cord protection strategies are critical and include:

Back to Table of Contents

10. Surveillance Guidelines

Evidence-based surveillance protocols guide frequency of imaging for known aneurysms below repair thresholds, post-repair follow-up, and screening of high-risk populations.

Screening

The U.S. Preventive Services Task Force (USPSTF) and SVS recommend one-time ultrasound screening for AAA in:

Surveillance of Known AAA (Below Repair Threshold)

Based on initial diameter:

Surveillance of Known TAA (Below Repair Threshold)

Post-EVAR Surveillance

Post-Open Repair Surveillance

Back to Table of Contents

11. Complications

Complications may arise from the aneurysm itself or from its repair.

Aneurysm-Related Complications

Perioperative Complications of Open Repair

Post-EVAR Complications

Back to Table of Contents

12. Prognosis

Prognosis depends on aneurysm size, rupture status, patient comorbidities, and type of repair performed.

Cardiovascular disease (coronary artery disease, stroke) is the leading cause of long-term mortality in surgically repaired aneurysm patients, underscoring the importance of comprehensive cardiovascular risk reduction.

Back to Table of Contents

13. Prevention

Primary prevention focuses on modifying risk factors for aneurysm formation and progression:

Back to Table of Contents

14. Recent Research

Significant advances have been made across the spectrum of aortic aneurysm research:

Back to Table of Contents

15. References

  1. Chaikof EL, Dalman RL, Eskandari MK, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018;67(1):2–77.e2. https://doi.org/10.1016/j.jvs.2017.10.044
  2. Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. Circulation. 2010;121(13):e266–e369. https://doi.org/10.1161/CIR.0b013e3181d4739e
  3. Erbel R, Aboyans V, Boileau C, et al. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J. 2014;35(41):2873–2926. https://doi.org/10.1093/eurheartj/ehu281
  4. Lederle FA, Kyriakides TC, Stroupe KT, et al. Open versus endovascular repair of abdominal aortic aneurysm (OVER trial) 14-year follow-up. N Engl J Med. 2019;380(22):2126–2135. https://doi.org/10.1056/NEJMoa1715064
  5. Greenhalgh RM, Brown LC, Powell JT, Thompson SG, Epstein D; EVAR Trial Participants. Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med. 2010;362(20):1872–1880. https://doi.org/10.1056/NEJMoa0911051
  6. Wanhainen A, Verzini F, Van Herzeele I, et al. European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg. 2019;57(1):8–93. https://doi.org/10.1016/j.ejvs.2018.09.020
  7. Crawford ES. Thoracoabdominal and abdominal aortic aneurysms involving renal, superior mesenteric, and celiac arteries. Ann Surg. 1974;179(5):763–772. https://doi.org/10.1097/00000658-197405000-00024
  8. Safi HJ, Miller CC III. Spinal cord protection in descending thoracic and thoracoabdominal aortic repair. Ann Thorac Surg. 1999;67(6):1937–1939. https://doi.org/10.1016/S0003-4975(99)00434-1
  9. Kuivaniemi H, Ryer EJ, Elmore JR, Tromp G. Understanding the pathogenesis of abdominal aortic aneurysms. Expert Rev Cardiovasc Ther. 2015;13(9):975–987. https://doi.org/10.1586/14779072.2015.1074861
  10. Thompson SG, Ashton HA, Gao L, Scott RA; Multicentre Aneurysm Screening Study Group. Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening Study. BMJ. 2009;338:b2307. https://doi.org/10.1136/bmj.b2307
  11. Biancari F, Catania A, D'Andrea V. Elective endovascular vs. open repair for abdominal aortic aneurysm in patients aged 80 years and older: systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2011;42(5):571–576. https://doi.org/10.1016/j.ejvs.2011.06.035
  12. Milewicz DM, Regalado E. Heritable thoracic aortic disease overview. In: Adam MP et al., eds. GeneReviews. University of Washington, Seattle; 2003 (updated 2019). https://doi.org/10.1146/annurev.med.57.121304.131341
  13. Nienaber CA, Clough RE. Management of acute aortic dissection. Lancet. 2015;385(9970):800–811. https://doi.org/10.1016/S0140-6736(14)61005-9
  14. Patel R, Sweeting MJ, Powell JT, Greenhalgh RM; EVAR Trial Investigators. Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial. Lancet. 2016;388(10058):2366–2374. https://doi.org/10.1016/S0140-6736(16)31135-7
  15. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT; UK Small Aneurysm Trial Participants. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation. 2004;110(1):16–21. https://doi.org/10.1161/01.CIR.0000133279.54043.2a
  16. Kent KC, Zwolak RM, Egorova NN, et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg. 2010;52(3):539–548. https://doi.org/10.1016/j.jvs.2010.05.090
  17. Bossone E, LaBounty TM, Eagle KA. Acute aortic syndromes: diagnosis and management, an update. Eur Heart J. 2018;39(9):739–749. https://doi.org/10.1093/eurheartj/ehx319
  18. Upchurch GR Jr, Escobar GA, Azizzadeh A, et al. Society for Vascular Surgery clinical practice guidelines of thoracic endovascular aortic repair for descending thoracic aortic aneurysms. J Vasc Surg. 2021;73(1S):55S–83S. https://doi.org/10.1016/j.jvs.2020.05.076

Back to Table of Contents